Mapussa
08045132067
+918209542042

Indacaterol Maleate and Glycopyrronium Bromide | GLYCOPRESS INDUS

Asthma by Steris Healthcare Pvt Ltd

Indacaterol Maleate and Glycopyrronium Bromide | GLYCOPRESS INDUS

INR 490 INR 703
In stockcod available
Phone Number

Email Address boost@sterispharma.com

Mon-Thu: 10 AM - 2 PM • Fri: 3 PM - 7AM

Other Website Visit our other website
Address Mapusa, Goa 403519, India

Mapussa, India, 403519

Description

GLYCOPRESS INDUS is a dual bronchodilator inhalation therapy developed to provide long-lasting relief in chronic respiratory conditions such as Chronic Obstructive Pulmonary Disease (COPD). Each dose contains Indacaterol Maleate Hemihydrate 110 mcg and Glycopyrronium Bromide 50 mcg, two clinically proven bronchodilators that work together to improve airflow, reduce breathlessness, and support better lung function. GLYCOPRESS INDUS is formulated as a dry powder for inhalation, providing targeted delivery directly into the lungs for faster and more effective symptom control. This combination is widely used under medical supervision to help patients manage chronic respiratory symptoms and maintain a better quality of life. Uses GLYCOPRESS INDUS is primarily prescribed for: Long-term maintenance treatment of Chronic Obstructive Pulmonary Disease (COPD) Relief of airway obstruction and chronic bronchitis Improvement of lung function in patients with emphysema Reducing episodes of breathlessness, wheezing, and chest tightness Enhancing overall respiratory capacity and daily activity levels in COPD patients This medication is not intended for acute asthma attacks or sudden breathing problems. Benefits GLYCOPRESS INDUS provides several clinically proven benefits, including: 1. Dual Bronchodilation for Maximum Airflow Indacaterol is a long-acting beta2-agonist (LABA), while Glycopyrronium is a long-acting muscarinic antagonist (LAMA). Together, they help relax airway muscles, allowing the patient to breathe more comfortably. 2. 24-Hour Symptom Control Both molecules offer prolonged bronchodilation, providing round-the-clock relief from COPD symptoms. 3. Quick and Targeted Lung Delivery The dry powder formulation ensures rapid absorption in the lungs, giving faster relief from breathlessness. 4. Reduced COPD Exacerbations Consistent use lowers the frequency of COPD flare-ups, hospital visits, and acute breathing episodes. 5. Improves Exercise Tolerance By enhancing airflow and reducing respiratory strain, patients often experience improved stamina and activity levels. 6. Simplified Once-Daily Dosing A once-daily inhalation improves patient compliance and ensures stable therapeutic effect throughout the day. Dosage The usual recommended dose is one inhalation once daily, or as advised by a healthcare professional. The dose should be taken at the same time every day for best results. The inhaler should be used exactly as instructed to ensure proper delivery of the medication. Patients must not exceed the prescribed dosage. This medicine is not indicated for sudden breathing difficulty; a rescue inhaler should be used in emergencies. Always follow your doctor’s instructions for duration and technique of use. Side Effects Some patients may experience mild to moderate side effects, including: Dry mouth Headache Sore throat or cough Dizziness Constipation Muscle cramps Increased heart rate Nasal irritation If symptoms such as severe chest pain, palpitations, difficulty urinating, or allergic reactions occur, seek immediate medical attention. Precautions and Warnings Not suitable for treating sudden breathing problems or asthma attacks. Avoid use in patients with known hypersensitivity to Indacaterol or Glycopyrronium Bromide. Use cautiously if you have heart disease, high blood pressure, thyroid disorders, urinary retention, or glaucoma. Pregnant and breastfeeding women should consult a doctor before using this inhaler. Do not combine with other long-acting bronchodilators unless prescribed. Keep out of reach of children and store in a cool, dry place. Regular monitoring of lung function is recommended during treatment. Conclusion GLYCOPRESS INDUS, containing Indacaterol Maleate Hemihydrate 110 mcg and Glycopyrronium Bromide 50 mcg, is an effective, long-acting inhalation therapy for managing COPD and improving overall breathing comfort. Its dual bronchodilator action, once-daily dosing, and sustained 24-hour relief make it a dependable choice for chronic respiratory care. When used under proper medical guidance, GLYCOPRESS INDUS helps patients breathe easier, remain active, and maintain better control over their respiratory health.

Specifications

Active ingredient Indacaterol Maleate Hemihydrate 110 mcg + Glycopyrronium Bromide 50 mcg Powder for Inhalation
Brand Name GLYCOPRESS INDUS
Manufactured By Steris Healthcare Pvt Ltd
Packaging size 30 Capsules
Dosage As Directed By the Physician
Storage Store In A Cool & Dry Place
Country of origin INDIA

Keywords

Other Medicines

view all